AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/129
ALTERNATIVE SPLICING LEADS TO THE FREQUENT COEXPRESSION OF P190BCR-ABL AND P210BCR-ABL TRANSCRIPTS IN THE CHRONIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: KAMELREID S LICHTY BD CALLUM J KEATING A
Citation: S. Kamelreid et al., ALTERNATIVE SPLICING LEADS TO THE FREQUENT COEXPRESSION OF P190BCR-ABL AND P210BCR-ABL TRANSCRIPTS IN THE CHRONIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA, Blood, 88(10), 1996, pp. 912-912
EFFECT OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION ON OVARIAN-FUNCTION
Authors: SCHIMMER A QUARTERMAIN M IMRIE K ALI V MCCRAE J DERZKO C KEATING A
Citation: A. Schimmer et al., EFFECT OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION ON OVARIAN-FUNCTION, Blood, 88(10), 1996, pp. 1038-1038
CYTOGENETIC ABNORMALITIES AT DIAGNOSIS ARE THE MOST IMPORTANT PROGNOSTIC FACTOR IN THE MYELODYSPLASTIC SYNDROMES (MDS)
Authors: BUCKSTEIN R CRUMP M IMRIE K SUTTON D PANTALONY D SHER G STEWART AK KEATING A
Citation: R. Buckstein et al., CYTOGENETIC ABNORMALITIES AT DIAGNOSIS ARE THE MOST IMPORTANT PROGNOSTIC FACTOR IN THE MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 2317-2317
AUTOLOGOUS (AUTO) AND ALLOGENEIC (ALLO) BONE-MARROW (BMT) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPCT) TRANSPLANTATION FOR MYELOMA
Authors: COUBAN S STEWART AK LOACH D PANZARELLA T MESSNER HA KEATING A MEHARCHAND J
Citation: S. Couban et al., AUTOLOGOUS (AUTO) AND ALLOGENEIC (ALLO) BONE-MARROW (BMT) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPCT) TRANSPLANTATION FOR MYELOMA, Blood, 88(10), 1996, pp. 2463-2463
TRANSPLANTATION OF BONE-MARROW STROMAL CELLS AS TREATMENT FOR A STEW CELL FACTOR-DEFECTIVE HEMATOPOIETIC MICROENVIRONMENT
Authors: BUBNIC SJ CLARK BR GUINN BA KEATING A
Citation: Sj. Bubnic et al., TRANSPLANTATION OF BONE-MARROW STROMAL CELLS AS TREATMENT FOR A STEW CELL FACTOR-DEFECTIVE HEMATOPOIETIC MICROENVIRONMENT, Blood, 88(10), 1996, pp. 2516-2516
NORMAL AND LEUKEMIC SCID-REPOPULATING CELLS (SRC) COEXIST IN THE BONE-MARROW AND PERIPHERAL-BLOOD FROM CML PATIENTS IN CHRONIC PHASE, WHEREAS LEUKEMIC SRC ARE DETECTED IN BLAST CRISIS
Authors: SIRARD C LAPIDOT T VORMOOR J CASHMAN JD DOEDENS M MURDOCH B JAMAL N MESSNER H ADDEY L MINDEN M LARAYA P KEATING A EAVES A LANSDORP PM EAVES CJ DICK JE
Citation: C. Sirard et al., NORMAL AND LEUKEMIC SCID-REPOPULATING CELLS (SRC) COEXIST IN THE BONE-MARROW AND PERIPHERAL-BLOOD FROM CML PATIENTS IN CHRONIC PHASE, WHEREAS LEUKEMIC SRC ARE DETECTED IN BLAST CRISIS, Blood, 87(4), 1996, pp. 1539-1548
CARBAMAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME IN A CHILD
Authors: KEATING A BLAHUNKA P
Citation: A. Keating et P. Blahunka, CARBAMAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME IN A CHILD, The Annals of pharmacotherapy, 29(5), 1995, pp. 538-539
A PHASE-I STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH STEM-CELL GENE MARKING IN MULTIPLE-MYELOMA
Authors: STEWART AK DUBE ID KAMELREID S KEATING A
Citation: Ak. Stewart et al., A PHASE-I STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH STEM-CELL GENE MARKING IN MULTIPLE-MYELOMA, Human gene therapy, 6(1), 1995, pp. 107-119
MINI-BEAM AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE BEFORE INTENSIVE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: COLWILL R CRUMP M COUTURE F DANISH R STEWART AK SUTTON DMC SCOTT JG SUTCLIFFE SB BRANDWEIN JM KEATING A
Citation: R. Colwill et al., MINI-BEAM AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE BEFORE INTENSIVE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 13(2), 1995, pp. 396-402
THE INFLUENCE OF PRIOR ALKYLATING AGENT THERAPY ON THE COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN MULTIPLE-MYELOMA
Authors: PRINCE HM IMRIE K KEATING A MEHARCHAND J STEWART AK
Citation: Hm. Prince et al., THE INFLUENCE OF PRIOR ALKYLATING AGENT THERAPY ON THE COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN MULTIPLE-MYELOMA, Experimental hematology, 23(8), 1995, pp. 755-755
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUROURACIL AND G-CSF - ABILITY TO SUPPORT MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY
Authors: PRINCE HM IMRIE K KEATING A TRIP K GOSS PE CRUMP M
Citation: Hm. Prince et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUROURACIL AND G-CSF - ABILITY TO SUPPORT MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY, Experimental hematology, 23(8), 1995, pp. 755-755
PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS IN MULTIPLE-MYELOMA - LIMITED VALUE OF REPEAT COLLECTIONS
Authors: PRINCE HM IMRIE K KEATING A GIROUARD C STEWART AK
Citation: Hm. Prince et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS IN MULTIPLE-MYELOMA - LIMITED VALUE OF REPEAT COLLECTIONS, Experimental hematology, 23(8), 1995, pp. 756-756
OPTIMIZING THE CD34(-1(+) CELL CONTENT OF PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS(), THY)
Authors: STEWART AK IMRIE K PRINCE HM ANANIA S KEATING A SUTHERLAND DR
Citation: Ak. Stewart et al., OPTIMIZING THE CD34(-1(+) CELL CONTENT OF PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS(), THY), Experimental hematology, 23(8), 1995, pp. 786-786
OUTCOME AFTER HIGH-DOSE ETOPOSIDE AND MELPHALAN AND AUTOTRANSPLANT INPATIENTS FAILING FRONT-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE
Authors: PRINCE HM CRUMP M IMRIE K STEWART K GIROUARD C KEATING A
Citation: Hm. Prince et al., OUTCOME AFTER HIGH-DOSE ETOPOSIDE AND MELPHALAN AND AUTOTRANSPLANT INPATIENTS FAILING FRONT-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE, Experimental hematology, 23(8), 1995, pp. 858-858
LONG-TERM DISEASE-FREE SURVIVAL AFTER INTENSIVE THERAPY AND AUTOTRANSPLANT IN PATIENTS FAILING INDUCTION CHEMOTHERAPY FOR INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA
Authors: PRINCE HM CRUMP M IMRIE K STEWART K GIROUARD C KEATING A
Citation: Hm. Prince et al., LONG-TERM DISEASE-FREE SURVIVAL AFTER INTENSIVE THERAPY AND AUTOTRANSPLANT IN PATIENTS FAILING INDUCTION CHEMOTHERAPY FOR INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA, Experimental hematology, 23(8), 1995, pp. 858-858
OPTIMIZING THE CD34(-1(+) STEM-CELL CONTENT OF PERIPHERAL-BLOOD COLLECTIONS() AND CD34(+)THY)
Authors: STEWART AK IMRIE K KEATING A ANANIA S NAYAR R SUTHERLAND DR
Citation: Ak. Stewart et al., OPTIMIZING THE CD34(-1(+) STEM-CELL CONTENT OF PERIPHERAL-BLOOD COLLECTIONS() AND CD34(+)THY), Experimental hematology, 23(14), 1995, pp. 1619-1627
SEVERE HEPATOTOXICITY FROM GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: PRINCE HM CHENG M CAMERON RG KEATING A
Citation: Hm. Prince et al., SEVERE HEPATOTOXICITY FROM GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(1), 1995, pp. 195-197
EFFECT OF ANTIMICROBIAL PROPHYLAXIS ON HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CIPROFLOXACIN VERSUS COTRIMOXAZOLE
Authors: IMRIE KR PRINCE HM COUTURE F BRANDWEIN JM KEATING A
Citation: Kr. Imrie et al., EFFECT OF ANTIMICROBIAL PROPHYLAXIS ON HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CIPROFLOXACIN VERSUS COTRIMOXAZOLE, Bone marrow transplantation, 15(2), 1995, pp. 267-270
MICROBIAL-CONTAMINATION OF HARVESTED BONE-MARROW AND PERIPHERAL-BLOOD
Authors: PRINCE HM PAGE SR KEATING A SARAGOSA RF VUKOVIC NM IMRIE KR CRUMP M STEWART AK
Citation: Hm. Prince et al., MICROBIAL-CONTAMINATION OF HARVESTED BONE-MARROW AND PERIPHERAL-BLOOD, Bone marrow transplantation, 15(1), 1995, pp. 87-91
OUTPATIENT BONE-MARROW HARVESTING - AN UPDATE
Authors: KOVACS MJ CRUMP M KEATING A
Citation: Mj. Kovacs et al., OUTPATIENT BONE-MARROW HARVESTING - AN UPDATE, Bone marrow transplantation, 15(1), 1995, pp. 125-127
INTERROGATING WHITENESS, (DE)CONSTRUCTING RACE
Authors: KEATING A
Citation: A. Keating, INTERROGATING WHITENESS, (DE)CONSTRUCTING RACE, College English, 57(8), 1995, pp. 901-918
MALIGNANT KARYOTYPE PREDICTS OUTCOME AFTER BUT NOT BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN TRANSPLANT CANDIDATES WITH ACUTEMYELOID-LEUKEMIA (AML)
Authors: IMRIE K PRINCE HM DUBE I CRUMP M STEWART AK KEATING A
Citation: K. Imrie et al., MALIGNANT KARYOTYPE PREDICTS OUTCOME AFTER BUT NOT BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN TRANSPLANT CANDIDATES WITH ACUTEMYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 157-157
MINI-BEAM FOR RELAPSED OR REFRACTORY LYMPHOMA PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
Authors: GIROUARD C DUFRESNE J IMRIE K PRINCE M STEWART AK KEATING A CRUMP M
Citation: C. Girouard et al., MINI-BEAM FOR RELAPSED OR REFRACTORY LYMPHOMA PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Blood, 86(10), 1995, pp. 203-203
AUTOTRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA (AML) - EFFECT OF PURGING WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4HC)
Authors: MILLER CB ROWLINGS PA JONES RJ KEATING A ZHANG MJ HOROWITZ MM
Citation: Cb. Miller et al., AUTOTRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA (AML) - EFFECT OF PURGING WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4HC), Blood, 86(10), 1995, pp. 385-385
LONG-TERM EVENT-FREE SURVIVAL (EFS) AFTER INTENSIVE THERAPY WITH ETOPOSIDE, MELPHALAN AND AUTOTRANSPLANT IN PATIENTS FAILING FRONT-LINE THERAPY FOR HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
Authors: PRINCE HM CRUMP M IMRIE K STEWART AK KEATING A
Citation: Hm. Prince et al., LONG-TERM EVENT-FREE SURVIVAL (EFS) AFTER INTENSIVE THERAPY WITH ETOPOSIDE, MELPHALAN AND AUTOTRANSPLANT IN PATIENTS FAILING FRONT-LINE THERAPY FOR HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 825-825
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>